| Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy MD Alison J. Rodger, PD Valentina Cambiano, RN Tina Bruun, ... JAMA 316 (2), 171-181, 2016 | 1684 | 2016 |
| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1010 | 2019 |
| Hepatic echinococcosis: clinical and therapeutic aspects G Nunnari, MR Pinzone, S Gruttadauria, BM Celesia, G Madeddu, ... World journal of gastroenterology: WJG 18 (13), 1448, 2012 | 456 | 2012 |
| The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65–74 years and more than 75 years G Guaraldi, A Malagoli, A Calcagno, C Mussi, BM Celesia, F Carli, ... BMC geriatrics 18, 1-10, 2018 | 158 | 2018 |
| Microbial translocation in chronic liver diseases MR Pinzone, BM Celesia, M Di Rosa, B Cacopardo, G Nunnari International journal of microbiology 2012, 2012 | 140 | 2012 |
| Auditing HIV testing rates across Europe: results from the HIDES 2 study D Raben, A Mocroft, M Rayment, VM Mitsura, V Hadziosmanovic, ... PloS one 10 (11), e0140845, 2015 | 74 | 2015 |
| Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily BM Celesia, D Castronuovo, MR Pinzone, F Bellissimo, MT Mughini, ... Eur Rev Med Pharmacol Sci 17 (16), 2218-24, 2013 | 68 | 2013 |
| Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir P Bonfanti, G Madeddu, R Gulminetti, N Squillace, G Orofino, P Vitiello, ... Aids 31 (3), 455-457, 2017 | 65 | 2017 |
| Kidney disease in HIV-infected patients. M Scarpino, MR Pinzone, M Di Rosa, G Madeddu, E Foca, F Martellotta, ... European Review for Medical & Pharmacological Sciences 17 (19), 2013 | 65 | 2013 |
| Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. B Cacopardo, L Nigro, W Preiser, A Fama, MI Satariano, J Braner, ... | 64 | 1996 |
| Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ... African Journal of Reproduction and Gynaecological Endoscopy 22 (1), 2019 | 63 | 2019 |
| LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals MR Pinzone, M Di Rosa, BM Celesia, F Condorelli, M Malaguarnera, ... Eur Rev Med Pharmacol Sci 17 (14), 1938-50, 2013 | 59 | 2013 |
| Factors associated with weight gain in people treated with dolutegravir L Taramasso, P Bonfanti, E Ricci, G Orofino, N Squillace, B Menzaghi, ... Open Forum Infectious Diseases 7 (6), ofaa195, 2020 | 54 | 2020 |
| Switch to dolutegravir plus rilpivirine dual therapy in cART-experienced subjects: an observational cohort AF Capetti, G Sterrantino, MV Cossu, GC Orofino, G Barbarini, ... PLoS One 11 (10), e0164753, 2016 | 54 | 2016 |
| Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study GV De Socio, E Ricci, G Parruti, L Calza, P Maggi, BM Celesia, G Orofino, ... Infection 44, 589-597, 2016 | 54 | 2016 |
| Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a … P Cahn, R Kaplan, PE Sax, K Squires, JM Molina, A Avihingsanon, ... The lancet HIV 4 (11), e486-e494, 2017 | 52 | 2017 |
| Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study S Nozza, A Malagoli, L Maia, A Calcagno, E Focà, G De Socio, S Piconi, ... Journal of Antimicrobial Chemotherapy 72 (10), 2879-2886, 2017 | 49 | 2017 |
| Ageing with HIV: a multidisciplinary review A Calcagno, S Nozza, C Muss, BM Celesia, F Carli, S Piconi, ... Infection 43, 509-522, 2015 | 46 | 2015 |
| Dolutegravir plus rilpivirine as a switch option in cART-experienced patients: 96-week data AF Capetti, MV Cossu, G Sterrantino, G Barbarini, S Di Giambenedetto, ... Annals of Pharmacotherapy 52 (8), 740-746, 2018 | 43 | 2018 |
| HCV and HBV infection among multitransfused thalassemics from eastern Sicily. B Cacopardo, R Russo, F Fatuzzo, S Cosentino, T Lombardo, R La Rosa, ... Infection 20 (2), 83-85, 1992 | 40 | 1992 |
